MAYNF

Healthcare Medical Distribution

Mayne Pharma Group Limited

$1.98

-0.02 -1.00% today

Price History

Not enough data

Key Stats

Market Cap

162.14M

Avg Volume

1,016

P/E (TTM)

9.43

EPS

$0.21

52W High

$4.00

52W Low

$1.40

Div. Yield

0.0%

Valuation

P/B Ratio

0.58

P/S Ratio

0.42

EV/EBITDA

3.75

EV/Revenue

0.32

PEG Ratio

2.52

Margins

Gross Margin 64.7%

Operating Margin (2.9%)

Net Margin 6.4%

EBITDA Margin 8.6%

Growth & Returns

Revenue Growth (YoY)

(12.0%)

Return on Equity

8.2%

Return on Assets

(1.7%)

Liquidity & Leverage

Current Ratio

1.31

Quick Ratio

0.98

Debt / Equity

0.11

Total Cash

80.00M

Total Debt

43.20M

About

Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.